IP Library Granted Patent US 7,833,523
Granted Patent B2
US 7,833,523 · App. 11/938,617 · Granted Nov 16, 2010

Compositions and methods for enzymatic detachment of bacterial and fungal biofilms

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,833,523
App. No.
11/938,617
Granted
Nov 16, 2010
Kind
B2
Abstract

Isolated nucleic acid sequences and amino acid sequences for soluble, β-N-acetylglucosaminidase or active fragments or variants thereof which promote detachment of bacterial cells from a biofilm are provided. An isolated mutant bacteria which forms biofilm colonies which tightly adhere to surface but which are unable to release cells into the medium or spread over the surface is also provided. In additions, methods are described for modulating detachment of bacterial cells from biofilm by mutating soluble, β-N-acetylglucosaminidase or altering its expression or activity are also provided. Also provided are compositions, methods and devices for preventing, inhibiting and treating bacterial infections.

Claims (13)

1. A wound dressing comprising an external surface coated or impregnated with a DispersinB (DspB) polypeptide encoded by a nucleic acid sequence of at least 95% sequence identity to nucleotides 61 to 1143 of SEQ ID NO:1, wherein the DspB polypeptide cleaves β-substituted N-acetylglucosaminide.

2. The wound dressing of claim 1 , wherein the wound dressing is a sponge, gauze, adhesive drape or catheter shield.

3. A transdermal patch comprising an external surface coated or impregnated with a DispersinB (DspB) polypeptide encoded by a nucleic acid sequence of at least 95% sequence identity to nucleotides 61 to 1143 of SEQ ID NO:1, wherein the DspB polypeptide cleaves β-substituted N-acetylglucosaminide.

4. The wound dressing of claim 1 , wherein the DspB polypeptide is SEQ ID NO:2.

5. The transdermal patch of claim 3 , wherein the DspB polypeptide is SEQ ID NO:2.

6. The wound dressing of claim 1 , further comprising a second polypeptide fused to the DspB polypeptide.

7. The wound dressing of claim 6 , wherein the second polypeptide is thrombin or fibronectin.

8. The wound dressing of claim 4 , further comprising a second polypeptide fused to the DspB polypeptide.

9. The wound dressing of claim 8 , wherein the second polypeptide is thrombin or fibronectin.

10. The transdermal patch of claim 3 , further comprising a second polypeptide fused to the DspB polypeptide.

11. The transdermal patch of claim 10 , wherein the second polypeptide is thrombin or fibronectin.

12. The transdermal patch of claim 5 , further comprising a second polypeptide fused to the DspB polypeptide.

13. The transdermal patch of claim 12 , wherein the second polypeptide is thrombin or fibronectin.

Assignments (1)
SECURITY INTEREST Recorded Nov 9, 2020
From: KANE BIOTECH INC.
To: PIVOT FINANCIAL INC.
Reel/Frame 054307/0264 →